These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2574 related articles for article (PubMed ID: 15647825)
41. Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3. Chun RF; Gacad M; Nguyen L; Hewison M; Adams JS J Mol Endocrinol; 2007 Aug; 39(2):81-9. PubMed ID: 17693608 [TBL] [Abstract][Full Text] [Related]
42. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987 [TBL] [Abstract][Full Text] [Related]
43. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes. Seuter S; Pehkonen P; Heikkinen S; Carlberg C Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200 [TBL] [Abstract][Full Text] [Related]
44. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway. Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474 [TBL] [Abstract][Full Text] [Related]
45. Highly potent transcriptional activation by 16-ene derivatives of 1,25-dihydroxyvitamin D3. Lack of modulation by 9-cis-retinoic acid of response to 1,25-dihydroxyvitamin D3 or its derivatives. Ferrara J; McCuaig K; Hendy GN; Uskokovic M; White JH J Biol Chem; 1994 Jan; 269(4):2971-81. PubMed ID: 8300629 [TBL] [Abstract][Full Text] [Related]
46. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators. Lee KC; Li J; Cole PA; Wong J; Kraus WL Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842 [TBL] [Abstract][Full Text] [Related]
47. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. Nguyen M; d'Alesio A; Pascussi JM; Kumar R; Griffin MD; Dong X; Guillozo H; Rizk-Rabin M; Sinding C; Bougnères P; Jehan F; Garabédian M J Bone Miner Res; 2006 Jun; 21(6):886-94. PubMed ID: 16753019 [TBL] [Abstract][Full Text] [Related]
48. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. Väisänen S; Dunlop TW; Sinkkonen L; Frank C; Carlberg C J Mol Biol; 2005 Jul; 350(1):65-77. PubMed ID: 15919092 [TBL] [Abstract][Full Text] [Related]
49. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction. Dwivedi PP; Omdahl JL; Kola I; Hume DA; May BK J Biol Chem; 2000 Jan; 275(1):47-55. PubMed ID: 10617584 [TBL] [Abstract][Full Text] [Related]
50. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Veenstra TD; Fahnestock M; Kumar R Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335 [TBL] [Abstract][Full Text] [Related]
51. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320 [TBL] [Abstract][Full Text] [Related]
52. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3. Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417 [TBL] [Abstract][Full Text] [Related]
53. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC; Quach HP; Vieth R; Pang KS Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451 [TBL] [Abstract][Full Text] [Related]
54. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Kim S; Yamazaki M; Zella LA; Shevde NK; Pike JW Mol Cell Biol; 2006 Sep; 26(17):6469-86. PubMed ID: 16914732 [TBL] [Abstract][Full Text] [Related]
55. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. Murayama A; Kim MS; Yanagisawa J; Takeyama K; Kato S EMBO J; 2004 Apr; 23(7):1598-608. PubMed ID: 15934135 [TBL] [Abstract][Full Text] [Related]
57. Transcriptional activation through the vitamin D receptor in osteoblasts. Kraichely DM; MacDonald PN Front Biosci; 1998 Aug; 3():d821-33. PubMed ID: 9682036 [TBL] [Abstract][Full Text] [Related]
58. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone. van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716 [TBL] [Abstract][Full Text] [Related]
59. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium. Healy KD; Zella JB; Prahl JM; DeLuca HF Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504 [TBL] [Abstract][Full Text] [Related]
60. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]